PPARGC1A and depressive symptom measurement: Nevertheless, the work provides a strong theoretical basis for the idea that PA can modulate PGC-1α, increase mitochondrial density, alter muscle fiber type, mitigate inflammation, and reduce depressive symptoms, particularly in persons with comorbid depression and diabetes.